Edition:
United States

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

9.14USD
12 Dec 2017
Change (% chg)

$-0.10 (-1.08%)
Prev Close
$9.24
Open
$9.30
Day's High
$9.60
Day's Low
$9.07
Volume
19,113
Avg. Vol
18,028
52-wk High
$13.37
52-wk Low
$7.44

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)

Overall

Beta: --
Market Cap(Mil.): $282.05
Shares Outstanding(Mil.): 30.86
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Edge Therapeutics reports qtrly loss per share $‍0.37​

* Edge Therapeutics reports third quarter 2017 financial results

Nov 01 2017

BRIEF-Edge Therapeutics appoints Rosemary Crane to Board of Directors

* Edge Therapeutics appoints Rosemary A Crane, pharmaceutical industry leader, to its Board Of Directors

Sep 19 2017

BRIEF-Edge Therapeutics to pay Oakwood $4.5 mln on achievement of regulatory milestones

* Edge Therapeutics - under restated development agreement, agreed to pay oakwood $4.5 million on achievement of regulatory milestones,no later than Apr 1 2019 Source: (http://bit.ly/2ttB0pm) Further company coverage:

Jul 06 2017

BRIEF-Edge Therapeutics enters commercial supply agreement for EG-1962 with Oakwood Laboratories

* Edge Therapeutics announces commercial supply agreement for EG-1962 with Oakwood Laboratories

Jul 06 2017

Earnings vs. Estimates